Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs. (Record no. 9417830)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01145 a2200301 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513133948.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199802s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0266-9536 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Kunkel, M W |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19980204 |
245 00 - TITLE STATEMENT | |
Title | Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Anti-cancer drug design |
Date of publication, distribution, etc. | Dec 1997 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 659-70 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Transformation, Neoplastic |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disulfides |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Screening Assays, Antitumor |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Signal Transduction |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Thioredoxin-Disulfide Reductase |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tumor Cells, Cultured |
General subdivision | drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kirkpatrick, D L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Johnson, J I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Powis, G |
773 0# - HOST ITEM ENTRY | |
Title | Anti-cancer drug design |
Related parts | vol. 12 |
-- | no. 8 |
-- | p. 659-70 |
No items available.